Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Anti-von Willebrand Factor Nanobody, Caplacizumab
(D11160)		2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab (D11160) 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
2Anti-von Willebrand Factor Nanobody, INN = Caplacizumab
(D11160)		2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab (D11160) 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
3CAPLACIZUMAB
(D11160)		1件: Caplacizumab1件: Caplacizumab (D11160) 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
4Caplacizumab (ALX-0081)
(D11160)		1件: Caplacizumab1件: Caplacizumab (D11160) 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
5Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081)
(D11160)		2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab (D11160) 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
6Caplacizumab (an anti-von Willebrand Factor Nanobody)
(D11160)		2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab (D11160) 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬